Senator Lummis: ‘America Must Establish a Strategic Bitcoin Reserve’

The recent surge in the price of gold, potentially indicating a blow-off top, seems to have had a positive impact on bitcoin (BTC). This trend is expected to continue, with bitcoin already being one of the best-performing global assets lately.

Following President Trump’s Liberation Day tariffs in early April, gold’s rally reached new heights, peaking above $3,500 per ounce on April 21. During this time, bitcoin was trading at $87,000, which was relatively flat from Liberation Day but down by about 20% from its all-time high in January.

However, gold has since dropped by nearly 10% to slightly above $3,200 per ounce, while bitcoin has surged by about 10% to reach a two-month high of $97,000.

According to Geoff Kendrick from Standard Chartered, bitcoin might be a better hedge than gold against strategic asset reallocation out of the U.S. He pointed out that the inflow into bitcoin funds has surpassed that into gold funds, indicating a shift in investor sentiment.

Kendrick also highlighted that the margin between bitcoin ETF inflows and gold was last seen during the week of the U.S. presidential election. Following that event, the price of bitcoin rose by more than 40% to above $100,000 within two months.

For half a billion years, nature has painstakingly refined proteins through evolution—adapting, mutating, and optimizing biological molecules to sustain life. Now, in a matter of months, artificial intelligence has achieved the same feat, marking a profound leap in biotechnology. The breakthrough, driven by ESM3, an advanced AI system developed by Meta, demonstrates the power of machine learning in revolutionizing how proteins are designed and understood. This technological milestone could fundamentally reshape medicine, bioengineering, materials science, and even the trajectory of life itself.

A New Era of Protein Design

Proteins are the foundation of all living organisms, performing a vast array of functions essential to life. Traditionally, designing new proteins has been an arduous process, requiring insights from nature’s own slow evolutionary experiments. Scientists have long relied on trial-and-error methods and minor modifications of existing proteins to develop new molecules for medicine and industry. Now, AI has completely upended this paradigm.

ESM3, the latest iteration of Meta’s Evolutionary Scale Modeling (ESM) project, is a powerful AI system trained on a database of 2.78 billion proteins. With 98 billion parameters, it ranks among the most sophisticated AI models ever created. Unlike previous computational biology tools, which primarily predict how proteins fold or tweak existing structures, ESM3 designs entirely new proteins from scratch—no natural template required.

From Evolution to Innovation

The true test of any AI-generated protein lies in whether it can function in real biological systems. One of ESM3’s most remarkable achievements is the creation of esmGFP, a glowing green protein that is 58% different from any naturally occurring counterpart. Evolution, operating under the constraints of natural selection, would have required millions of years to produce such a distinct protein. ESM3, in contrast, generated it in a fraction of that time. This discovery not only confirms that AI can create viable, functional proteins but also suggests that AI-driven methods could surpass evolutionary constraints to develop new biomolecules with unprecedented properties.

Implications for Medicine and Biotechnology

The ability to design proteins on demand opens the door to groundbreaking applications in healthcare, pharmaceuticals, and bioengineering. Some of the most immediate and profound impacts could include:

1. Drug Discovery & Personalized Medicine
   • AI-generated proteins could lead to new treatments for diseases that currently have no cure. Instead of modifying existing proteins, scientists can now create entirely new therapeutic molecules tailored to target specific conditions.
   • Personalized medicine could see a breakthrough as AI helps design customized proteins based on an individual’s genetic makeup, improving the efficacy of treatments.
2. Stronger Materials & Sustainable Solutions
   • Proteins are already used in materials science to create biodegradable plastics, stronger fibers, and self-healing materials. AI-driven protein design could accelerate these developments, yielding materials that are stronger, lighter, and more sustainable than anything nature has evolved.
   • Enzymes optimized by AI could enhance industrial processes by increasing efficiency and reducing waste, leading to more environmentally friendly manufacturing.
3. Advancing Clean Energy
   • AI-designed proteins could contribute to the development of biofuels and artificial photosynthesis, offering innovative ways to harness energy sustainably.
   • Custom enzymes could help break down pollutants, aiding in environmental cleanup efforts and combating climate change.
4. Food Security & Agriculture
   • The food industry could benefit from AI-driven proteins that improve crop resilience, enhance nutrition, and develop alternative protein sources for a growing global population.
   • Synthetic proteins designed for lab-grown meat or dairy alternatives could make plant-based and cultured foods more affordable and scalable, reducing reliance on traditional livestock farming.

Could AI Predict the Future of Life?

Beyond practical applications, AI’s ability to generate proteins from scratch raises an even more profound question: Can AI predict the future of biological evolution?

Evolution operates through random mutations and natural selection, which shape organisms over millions of years. However, AI can now explore biological possibilities that nature has never encountered. By modeling potential evolutionary paths, AI systems like ESM3 could offer insights into how life might adapt to new environments, evolve under extreme conditions, or even arise on other planets.

This capability has profound implications for astrobiology, synthetic biology, and our fundamental understanding of life itself. If AI can generate proteins that nature never produced, could it also help us anticipate the next stage of evolution—or even guide it?

AI-Designed Proteins: A Turning Point for Science

The development of ESM3 is more than just a scientific milestone—it represents a paradigm shift in how we understand and manipulate the fundamental molecules of life. Unlike previous advances in computational biology, which focused on deciphering natural proteins, ESM3 demonstrates that AI can now invent them. This puts us on the cusp of a future where scientists no longer have to wait for nature’s slow evolutionary experiments. Instead, they can create entirely new biological solutions in real time.

With AI-driven protein design moving from theory to reality, we are entering an era where the boundaries of medicine, biotechnology, and materials science are no longer set by evolution, but by human ingenuity.

The question is no longer whether AI can change life as we know it—it already has. The only question now is: What will we create next?

Source: bioRxiv

Elon Musk’s offer to buy OpenAI for $97.4 billion, backed by a consortium of investors, could force OpenAI’s board of directors to reassess how it is valuing the nonprofit.

Sam Altman stated that he believes Musk’s offer is merely a tactic to slow OpenAI down. In response, he expressed willingness to buy X (Twitter) for $9.74 billion—a figure that some might find offensive to Musk, given X’s current valuation.

OpenAI is currently negotiating how much equity Microsoft should get in its for-profit company – satisfying all those parties was already complicated. The company must get approval for its conversion from attorneys general in California and Delaware – these officials will oversee the valuation of the nonprofit’s assets during a sale to ensure it is properly compensated.